Metraipolis › archive › dc_97393281db48

Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis — Europe PMC PMID:36383618

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36383618
DOI
10.1371/journal.pone.0277655
License (as archived)
CC0-1.0
Archived
2026-10-15T16:03:06.891Z
SHA-256 of the archived text
6cba6d820cee82e6c46db18131324b7b0b99184883f91fd3dc54e8b839973be0
Stable URL of this page
https://metraipolis.com/documento/dc_97393281db48

How to cite

Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis — Europe PMC PMID:36383618 — Europe PMC (en), https://europepmc.org/article/MED/36383618 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_97393281db48 (Metraipolis archive dc_97393281db48, sha256 6cba6d820cee82e6c46db18131324b7b0b99184883f91fd3dc54e8b839973be0)
BibTeX
@misc{dc97393281db48,
  title = {Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis — Europe PMC PMID:36383618},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36383618},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_97393281db48; sha256 6cba6d820cee82e6c46db18131324b7b0b99184883f91fd3dc54e8b839973be0},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36383618. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Large cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development. Objectives: Here, we seek to characterize the clinicopathologic risk factors that predispose patients with SS to develop LCT. Methods: We retrospectively evaluated all SS patient records available in the Michigan Medicine Cancer Registry from 2010-2021. Clinical and pathologic variables were compared between groups. The Kaplan-Meier method and log-rank test were used to assess overall survival. Results: Of 28 SS patients identified, eight patients experienced LCT, and 20 did not (NLCT). Peak lactate dehydrogenase (LDH) before LCT (p = 0.0012), maximum total body surface area (TBSA) involvement before LCT (p = 0.0114), absolute CD8+ cell count measured on flow cytometry at diagnosis of SS (p = 0.0455) and at the most recent blood draw (p = 0.00736), and ulceration on biopsy (p = 0.0034) were significant clinicopathologic variables identified between the SS patients that developed LCT versus those that did not. Conclusions: Maximum TBSA involvement, peak LDH, presence of ulceration, and decreased levels of CD8+ cells in the peripheral blood may predict the development of LCT in patients with SS.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-11-16).
Identificativi: PMID 36383618 · PMCID PMC9668185 · DOI 10.1371/journal.pone.0277655.
Descrittori MeSH principali: Mycosis Fungoides; Sezary Syndrome; Skin Neoplasms.
Pagina: https://europepmc.org/article/MED/36383618 — https://doi.org/10.1371/journal.pone.0277655. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-15T15:31:20.439Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.